Target intelligence / Profile preview

Copper-dependent cell death (Cuproptosis) (Cuproptosis)

Target
Cuproptosis
Molecular classification
Regulated cell death pathway, Metabolic pathway, Mitochondrial machinery
01

Overview

Copper-dependent cell death, scientifically termed cuproptosis, is a recently identified form of regulated cell death characterized by the direct binding of copper ions to lipoylated components of the tricarboxylic acid (TCA) cycle. This binding occurs specifically at the dihydrolipoamide S-acetyltransferase (DLAT) subunit of the pyruvate dehydrogenase complex, leading to the aggregation of lipoylated proteins and the subsequent loss of iron-sulfur cluster proteins (Tsvetkov et al., 2022; PubMed: 35298263). These molecular events trigger profound proteotoxic stress that ultimately results in cell death, a pathway distinct from apoptosis, ferroptosis, or necroptosis. Cuproptosis is primarily regulated by the enzyme Ferredoxin 1 (FDX1), which reduces copper to its more toxic form and maintains the lipoylation of TCA cycle enzymes (Li et al., 2022; PubMed: 36545166). In a therapeutic context, this pathway is targeted in cancer research, as many tumor cells exhibit a high dependency on mitochondrial metabolism and are therefore hypersensitive to copper-induced stress. Drugs such as copper ionophores (e.g., Elesclomol) are being investigated for their ability to transport copper into cells and selectively induce cuproptosis in metabolically active cancer cells (Kahlson & Colvin, 2022; PubMed: 35508605).

Other names
CuproptosisCopper-induced cell deathCopper-dependent regulated cell deathCopper-triggered mitochondrial cell death
02

Mechanism of action

Copper ionophores (such as Elesclomol) facilitate the transport of copper ions across the plasma membrane, leading to an intracellular accumulation of copper. These copper ions are reduced by Ferredoxin 1 (FDX1) and subsequently bind to the lipoylated proteins of the TCA cycle, most notably Dihydrolipoamide S-acetyltransferase (DLAT). This binding induces the aggregation of these proteins and the inhibition of iron-sulfur cluster protein synthesis, resulting in proteotoxic stress and mitochondrial dysfunction that triggers cell death (Tsvetkov et al., 2022; PubMed: 35298263; Wang et al., 2022; PubMed: 36248107).

03

Biological functions

Cell deathTricarboxylic acid (TCA) cycle regulationMitochondrial metabolismCopper homeostasisProteotoxic stress responseIron-sulfur (Fe-S) cluster protein maintenance
04

Disease associations

Cancer (especially Clear Cell Renal Cell Carcinoma, Melanoma, and Hepatocellular Carcinoma)Wilson diseaseNeurodegenerative diseaseMenkes diseaseCardiovascular disease
05

Safety considerations

Systemic copper toxicity (hepatotoxicity and nephrotoxicity)Off-target effects in high-metabolic organs (liver and brain)Neurotoxicity due to disrupted copper homeostasisNarrow therapeutic window for copper ionophoresPotential for inducing oxidative stress in non-target tissues
06

Interacting drugs

Elesclomol

5 more in the full profile.

07

Biomarkers

Ferredoxin 1 (FDX1) expression levelDihydrolipoamide S-acetyltransferase (DLAT) lipoylation statusLipoic acid synthetase (LIAS) expressionIntracellular copper concentrationPyruvate dehydrogenase complex (PDH) activity

Beyond the preview

Go deeper on Copper-dependent cell death (Cuproptosis) (Cuproptosis).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Copper-dependent cell death (Cuproptosis) (Cuproptosis).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call